Literature DB >> 8437794

Maternal tobacco use and substance abuse: reported prevalence rates and associations with the delivery of small for gestational age neonates.

L C Castro1, C Azen, C J Hobel, L D Platt.   

Abstract

OBJECTIVE: To determine the changes in reported prevalence rates of tobacco use and substance abuse in a population of pregnant women, as well as to evaluate the associations between such use and sociodemographic characteristics and the delivery of small for gestational age (SGA) neonates.
METHODS: We studied 7741 women who delivered at Cedars-Sinai Medical Center from 1986-1990. Antenatal and delivery information was entered prospectively into the computerized perinatal data base. Subjects were classified according to tobacco use and substance abuse status. We defined SGA as a birth weight less than the tenth percentile for gestational age at delivery. Univariate and multivariate analyses were used to determine the associations between SGA and tobacco use, substance abuse, and sociodemographic characteristics.
RESULTS: We found that the reported prevalence rates of tobacco use and substance abuse declined between 1986-1990 (10 versus 6% and 7 versus 2%, respectively; P < .001). Tobacco use and substance abuse were reported as being highest in black women (11 and 6%) and lowest in Asian and Hispanic women (4 and 3%), a significant difference (P < .001). Tobacco use and race-ethnicity were found to have the strongest independent associations with SGA. The incidence of SGA was highest in black women identified as tobacco users and substance abusers.
CONCLUSIONS: The reported rates of tobacco use and substance abuse varied by year, race-ethnicity, and insurance status. There were significant associations between maternal tobacco use, substance abuse, and race-ethnicity and the incidence of SGA neonates.

Entities:  

Mesh:

Year:  1993        PMID: 8437794

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse.

Authors:  E S Hall; S L Wexelblatt; J M Greenberg
Journal:  J Perinatol       Date:  2016-07-07       Impact factor: 2.521

2.  Toxicity Mechanisms of Cigarette Smoke on Mouse Fetus Mitochondria.

Authors:  Parvaneh Naserzadeh; Mir-Jamal Hosseini; Baharak Mohamadzadeh Asl; Jalal Pourahmad
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  Pharmacological treatment for pregnant women who smoke cigarettes.

Authors:  Bc Chan; G Koren
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

4.  Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study.

Authors:  Lauren H Theilen; Rebecca B McNeil; Shannon Hunter; William A Grobman; Corette B Parker; Janet M Catov; Victoria L Pemberton; Deborah B Ehrenthal; David M Haas; Matthew K Hoffman; Judith H Chung; Farhana Mukhtar; Zorayr Arzumanyan; Brian Mercer; Samuel Parry; George R Saade; Hyagriv N Simhan; Ronald J Wapner; Robert M Silver
Journal:  Am J Perinatol       Date:  2021-08-06       Impact factor: 3.079

5.  Prenatal Exposure to Gutkha, a Globally Relevant Smokeless Tobacco Product, Induces Hepatic Changes in Adult Mice.

Authors:  Shannon Doherty Lyons; Jason L Blum; Carol Hoffman-Budde; Pamela B Tijerina; M Isabel Fiel; Daniel J Conklin; Francesca Gany; Joseph A Odin; Judith T Zelikoff
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.